New York's Monkeypox Emergency Sunsets
With monkeypox virus (MPX) cases down from the peak in late July 2022, both New York City and New York state governments are abruptly ending their emergencies.
New York joins the city of San Francisco, which discontinued its MPX emergency on October 27, 2022.
Dr. Ted Long, SVP at New York City Health + Hospitals informed the New York Times on November 17, 2022, he was working on a proposal to bring back the vaccination vans.
New York's governor had recently extended the Declaration of a Statewide Disaster Emergency on September 27, 2022.
The good news is MPX cases have significantly decreased in NYC.
As of November 7, 2022, NYC Health disclosed there were 3,758 confirmed MPX cases since May 2022.
And there is an ample supply of the two-dose JYNNEOS® (MVA-BN) vaccine.
NYC's total number of vaccinations is about 149,644, split between first doses (2/3) and second doses.
As of November 15, 2022, 1,090,222 JYNENOS doses has administered in 57 U.S. Jurisdictions, with approximately 628,000 persons receiving ≥1 dose and 390,000 persons receiving the complete 2-dose series.
About 854,713 vials were distributed by the U.S. government.
As of November 2022, Jynneos is the only U.S. FDA-approved monkeypox vaccine for U.S. military and civilian use, but it is not sold commercially.
Regarding the vaccine's efficacy, there remains limited research showing how well JYNNEOS works against this version of MPX.
Additional monkeypox vaccine information is posted at PrecisionVaccinations.com/Monkeypox.
Our Trust Standards: Medical Advisory Committee